Sumitomo Dainippon Pharma approves commitment to MPM Oncology Innovations Fund
The Japanese pharmaceutical company has backed a multi-regional healthcare fund.
Nearly there!
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group .-
Sign in or Register
-
Issues with signing in? Click here
Don't have an account? Register now
-
- Database
- Quick Search
- News & Analysis
- Rankings & Reports
- PEI 300
- Future 40: the next leaders of PE
- Private Equity Fundraising Reports
- Spotlight Podcast Series
- LP Perspectives 2020
- Special Reports
- PEI Awards 2019aa
- The A-Z of Value Creation
- Responsible Investment 2020
- The A-Z of Impact Investing
- Investing in Technology
- Operational Excellence Special 2019
- Secondaries Special
- US Mid-Market 2019
- Hidden value in Africa
- Fund Administration Special
- Legal Special
- The Future of Private Equity 2019
- Japan Special
- Events
- Bookstore
